Medical technology firm BD targets net zero emissions by 2050

Last year, BD committed to reduce Scope 1 and 2 greenhouse gas emissions by 46% by 2030 and become carbon neutral across its direct operations by 2040

Net Hero Podcast

Global medical technology company Becton, Dickinson and Company (BD) has pledged to achieve net zero emissions by 2050 by setting science-based targets.

It has officially signed on to the Business Ambition for 1.5°C, the largest alliance dedicated to achieving the net zero goal over the next three decades, as well as the UN Race to Zero campaign.

Last year, BD committed to reduce Scope 1 and 2 greenhouse gas emissions by 46% by 2030 and become carbon neutral across its direct operations by 2040.

The company seeks to achieve its goals through sourcing renewable energy for its operations, minimising its environmental footprint and conserving natural resources, establishing a supplier responsibility evaluation methodology, reducing priority materials of concern in specified product categories and improving the lifecycle impacts of current and future products.

Tom Polen, Chairman, CEO and President of BD said: “We are committed to using our scale and influence to help address climate change and its effect on our environment and health systems around the world.

“We are reducing the environmental impact of our product portfolio by changing the way we approach plastics and packaging materials and working closely with our supply chain partners to reduce our carbon footprint. We are taking the next step by joining the Race to Zero and setting science-based targets to help address the worst effects of climate change – including the irreversible harm to human health – particularly in vulnerable people and populations.”